Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free NBIX Stock Alerts $137.76 -1.21 (-0.87%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Neurocrine Biosciences Stock Price Performance5 Day Performance+4.36%1 Month Performance-2.41%3 Month Performance-3.09%6 Month Performance+27.65%Year-To-Date Performance+4.55%1 Year Performance+34.11% Receive NBIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). NBIX Stock Chart for Friday, April, 26, 2024 NBIX Chart by TradingView Neurocrine Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$138.97$137.76-0.87%$139.37$136.06706,045 shs$13.71 billion04/24/2024$140.09$138.97-0.80%$144.70$138.01927,988 shs$13.83 billion04/23/2024$133.66$140.09+4.81%$145.00$139.221.61 million shs$13.94 billion04/22/2024$132.00$133.66+1.26%$134.18$131.79575,066 shs$13.30 billion04/19/2024$132.54$132.00-0.41%$133.65$130.13556,052 shs$13.14 billion04/18/2024$133.23$132.54-0.52%$134.20$131.00549,307 shs$13.19 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$132.99$133.23+0.18%$134.44$131.36571,073 shs$13.26 billion04/16/2024$131.74$132.99+0.95%$135.17$131.491.03 million shs$13.23 billion04/15/2024$134.66$131.74-2.17%$137.00$131.52767,232 shs$13.11 billion04/12/2024$135.93$134.66-0.93%$137.78$134.63577,029 shs$13.40 billion04/11/2024$138.09$135.93-1.56%$138.67$135.28808,737 shs$13.53 billion04/10/2024$138.94$138.09-0.61%$140.54$137.99639,131 shs$13.74 billion04/09/2024$139.44$138.94-0.36%$141.38$138.00598,996 shs$13.83 billion04/08/2024$138.92$139.44+0.37%$139.68$137.72615,637 shs$13.88 billion04/05/2024$137.61$138.92+0.95%$139.75$136.03458,596 shs$13.82 billion04/04/2024$137.59$137.61+0.01%$140.43$136.741.02 million shs$13.69 billion04/03/2024$137.74$137.59-0.11%$140.19$137.36614,130 shs$13.69 billion04/02/2024$141.38$137.74-2.57%$140.61$136.12913,859 shs$13.71 billion04/01/2024$137.92$141.38+2.51%$141.73$136.85995,764 shs$14.07 billion03/29/2024$137.92$137.92$138.72$135.971.25 million shs$13.72 billion03/28/2024$137.83$137.92+0.07%$138.72$135.971.25 million shs$13.72 billion03/27/2024$141.16$137.83-2.36%$141.73$133.431.17 million shs$13.72 billion03/26/2024$140.25$141.16+0.65%$142.31$139.94594,680 shs$14.05 billion03/25/2024$141.43$140.25-0.83%$142.08$138.85498,306 shs$13.96 billion03/22/2024$143.74$141.43-1.61%$145.42$137.35938,508 shs$14.07 billion03/21/2024$140.65$143.74+2.20%$148.37$139.312.51 million shs$14.30 billion03/20/2024$140.87$140.65-0.16%$141.64$137.14653,029 shs$14.00 billion03/19/2024$139.44$140.87+1.03%$141.06$138.32754,518 shs$14.02 billion03/18/2024$139.10$139.44+0.24%$141.76$138.57664,650 shs$13.88 billion03/15/2024$139.16$139.10-0.04%$142.15$138.671.73 million shs$13.84 billion03/14/2024$141.80$139.16-1.86%$142.50$137.831.17 million shs$13.85 billion03/13/2024$137.74$141.80+2.95%$141.91$138.321.07 million shs$14.11 billion03/12/2024$138.61$137.74-0.63%$139.98$137.66639,870 shs$13.71 billion03/11/2024$139.22$138.61-0.44%$140.25$137.31616,799 shs$13.79 billion03/08/2024$135.33$139.22+2.87%$140.33$136.27998,711 shs$13.85 billion03/07/2024$132.25$135.33+2.33%$135.61$132.62728,303 shs$13.47 billion03/06/2024$133.67$132.25-1.06%$134.57$131.65623,780 shs$13.16 billion03/05/2024$133.12$133.67+0.41%$135.15$132.12878,234 shs$13.30 billion03/04/2024$131.30$133.12+1.39%$134.28$131.01962,863 shs$13.25 billion03/01/2024$130.40$131.30+0.69%$132.60$129.151.32 million shs$13.07 billion“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).02/29/2024$134.66$130.40-3.16%$136.10$130.041.72 million shs$12.98 billion02/28/2024$136.03$134.66-1.01%$136.03$133.82842,210 shs$13.40 billion02/27/2024$135.58$136.03+0.33%$136.56$134.65818,609 shs$13.54 billion02/26/2024$134.18$135.58+1.04%$136.20$133.17776,968 shs$13.49 billion02/23/2024$133.37$134.18+0.61%$134.65$132.73542,052 shs$13.35 billion02/22/2024$130.65$133.37+2.08%$133.84$130.55646,731 shs$13.27 billion02/21/2024$132.65$130.65-1.51%$133.61$129.93812,310 shs$13.00 billion02/20/2024$132.31$132.65+0.26%$134.16$131.59811,598 shs$13.20 billion02/19/2024$132.31$132.31$134.82$132.23725,700 shs$13.17 billion02/16/2024$134.00$132.31-1.26%$134.82$132.23725,785 shs$13.17 billion02/15/2024$131.77$134.00+1.69%$134.13$131.40637,962 shs$13.33 billion02/14/2024$133.84$131.77-1.55%$135.99$131.56780,746 shs$13.11 billion02/13/2024$130.43$133.84+2.61%$134.93$129.511.77 million shs$13.15 billion02/12/2024$132.30$130.43-1.41%$133.17$130.161.01 million shs$12.81 billion02/09/2024$134.42$132.30-1.58%$135.42$131.72693,315 shs$13.00 billion02/08/2024$136.29$134.42-1.37%$136.78$132.501.01 million shs$13.21 billion02/07/2024$142.96$136.29-4.67%$143.16$128.001.64 million shs$13.39 billion02/06/2024$141.66$142.96+0.92%$143.16$140.871.03 million shs$14.05 billion02/05/2024$141.74$141.66-0.06%$141.97$139.72648,805 shs$13.92 billion02/02/2024$142.45$141.74-0.50%$142.91$141.06395,767 shs$13.93 billion02/01/2024$139.77$142.45+1.92%$142.69$138.43858,408 shs$14.00 billion01/31/2024$142.06$139.77-1.61%$142.22$139.431.15 million shs$13.73 billion01/30/2024$142.22$142.06-0.11%$143.00$141.68474,572 shs$13.96 billion01/29/2024$142.15$142.22+0.05%$143.35$141.89597,817 shs$13.97 billion01/26/2024$141.01$142.15+0.81%$142.74$140.81716,579 shs$13.97 billion01/25/2024$140.11$141.01+0.64%$141.27$139.17584,727 shs$13.85 billion Related Companies: Repligen Stock Chart Exelixis Stock Chart Halozyme Therapeutics Stock Chart Denali Therapeutics Stock Chart Adaptive Biotechnologies Stock Chart Biogen Stock Chart Bio-Techne Stock Chart Qiagen Stock Chart Vaxcyte Stock Chart Revolution Medicines Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.